World's Best Scientists 2026 revealed!
Patrick Vermersch

Patrick Vermersch

D-Index & Metrics

Medicine

D-Index
78
Citations
26794
World Ranking
17909
National Ranking
596

Patrick Vermersch publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Patrick Vermersch sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 642 publications — 76th percentile

76% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Patrick Vermersch D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Patrick Vermersch sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 78 D-Index — 12th percentile

12% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Patrick Vermersch is affiliated with the University of Lille in France, specializing primarily in the field of Medicine. Their research contributions encompass several subfields including Pathology and Forensic Medicine, Neurology, Oncology, Rheumatology, and Genetics.

The scientist's work addresses a range of medical topics with notable focus on multiple sclerosis and related neurological conditions. Key areas of research include:

  • Multiple Sclerosis Research Studies
  • Polyomavirus and related diseases
  • Chronic Lymphocytic Leukemia Research
  • Peripheral Neuropathies and Disorders
  • Systemic Sclerosis and Related Diseases
  • Systemic Lupus Erythematosus Research
  • Acute Lymphoblastic Leukemia research

Patrick Vermersch has contributed to numerous papers, several of which are notable for their publication outcomes and citation impact. Recent significant publications include:

  • Safety and efficacy of tolebrutinib, an oral brain-penetrant BTK inhibitor, in relapsing multiple sclerosis: a phase 2b, randomised, double-blind, placebo-controlled trial (2021) published in The Lancet Neurology
  • The radiologically isolated syndrome: revised diagnostic criteria (2023) published in Brain
  • Optical coherence tomography in multiple sclerosis: A 3-year prospective multicenter study (2021) published in Annals of Clinical and Translational Neurology
  • Masitinib for mild-to-moderate Alzheimer's disease: results from a randomized, placebo-controlled, phase 3, clinical trial (2023) published in Alzheimer s Research & Therapy
  • Siponimod and Cognition in Secondary Progressive Multiple Sclerosis (2021) published in Neurology

The scientist frequently collaborates with several other researchers, some of whom appear consistently as coauthors in their publications. Frequent collaborators include:

  • Gavin Giovannoni
  • Xavier Montalbán
  • de Sèze
  • Heinz Wiendl
  • Celia Oreja-Guevara

Patrick Vermersch's research is disseminated through several key academic journals and publication venues. These are:

  • Neurology
  • Revue Neurologique
  • Multiple Sclerosis and Related Disorders
  • Multiple Sclerosis Journal
  • Neurology and Therapy

Best Publications

  • Atrophy of medial temporal lobes on MRI in “probable” Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates

    P Scheltens;D Leys;F Barkhof;D Huglo

  • A semiquantative rating scale for the assessment of signal hyperintensities on magnetic resonance imaging

    P. Scheltens;F. Barkhof;D. Leys;J.P Pruvo

  • A placebo-controlled trial of oral cladribine for relapsing multiple sclerosis.

    Gavin Giovannoni;Giancarlo Comi;Stuart Cook;Kottil Rammohan

  • The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer’s disease

    A. Delacourte;J.P. David;N. Sergeant;L. Buée

  • Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

    James F Howard;Kimiaki Utsugisawa;Michael Benatar;Hiroyuki Murai

  • Neuromyelitis optica and non organ-specific autoimmunity.

    Sean J. Pittock;Vanda A. Lennon;Jerome de Seze;Patrick Vermersch

  • Neurologic manifestations in primary Sjögren syndrome: a study of 82 patients.

    Sophie Delalande;Jérôme de Seze;Anne-Laure Fauchais;Eric Hachulla

  • Systemic vascular smooth muscle cell impairment in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy.

    Marie Magdeleine Ruchoux;Djelloul Guerouaou;Benedicte Vandenhaute;Jean-Pierre Pruvo

  • Teriflunomide versus subcutaneous interferon beta-1a in patients with relapsing multiple sclerosis: a randomised, controlled phase 3 trial:

    Patrick Vermersch;Anna Czlonkowska;Luigi M E Grimaldi;Christian Confavreux

  • Retinal thickness measured with optical coherence tomography and risk of disability worsening in multiple sclerosis: a cohort study

    Elena H. Martinez-Lapiscina;Sam Arnow;James A. Wilson;Shiv Saidha

  • Dysregulation of human brain microtubule-associated tau mRNA maturation in myotonic dystrophy type 1

    Nicolas Sergeant;Bernard Sablonnière;Suzanna Schraen-Maschke;Antoine Ghestem

  • Safety and efficacy of cladribine tablets in patients with relapsing-remitting multiple sclerosis: Results from the randomized extension trial of the CLARITY study.

    Gavin Giovannoni;Per Soelberg Sorensen;Stuart Cook;Kottil Rammohan

  • Radiologically Isolated Syndrome: 5-Year Risk for an Initial Clinical Event

    Darin T. Okuda;Aksel Siva;Orhun Kantarci;Matilde Inglese

  • Quality control for retinal OCT in multiple sclerosis: validation of the OSCAR-IB criteria

    S. Schippling;L. J. Balk;F. Costello;P. Albrecht

  • Sustained disease-activity-free status in patients with relapsing-remitting multiple sclerosis treated with cladribine tablets in the CLARITY study: a post-hoc and subgroup analysis

    Gavin Giovannoni;Stuart Cook;Kottil Rammohan;Peter Rieckmann

  • Immunosuppressive therapy is more effective than interferon in neuromyelitis optica

    C Papeix;J-S Vidal;J de Seze;C Pierrot-Deseilligny

  • Neuromyelitis optica in France A multicenter study of 125 patients

    N. Collongues;R. Marignier;H. Zéphir;C. Papeix

  • Acute myelopathies: Clinical, laboratory and outcome profiles in 79 cases.

    Jérôme de Seze;Tanya Stojkovic;Guillaume Breteau;Christian Lucas

  • Effect of oral cladribine on time to conversion to clinically definite multiple sclerosis in patients with a first demyelinating event (ORACLE MS): a phase 3 randomised trial

    Thomas P. Leist;Giancarlo Comi;Bruce A C Cree;Patricia K. Coyle

  • Devic's neuromyelitis optica: clinical, laboratory, MRI and outcome profile

    J. de Seze;T. Stojkovic;D. Ferriby;J.-Y. Gauvrit

Frequent Co-Authors

Gavin Giovannoni
Gavin Giovannoni Queen Mary University of London
Giancarlo Comi
Giancarlo Comi Vita-Salute San Raffaele University
Per Soelberg Sørensen
Per Soelberg Sørensen University of Copenhagen
Bruce A. C. Cree
Bruce A. C. Cree University of California, San Francisco
Ludwig Kappos
Ludwig Kappos University Hospital of Basel
Ralf Gold
Ralf Gold Ruhr University Bochum
Xavier Montalban
Xavier Montalban Autonomous University of Barcelona
Amit Bar-Or
Amit Bar-Or University of Pennsylvania
Frédéric Blanc
Frédéric Blanc University of Strasbourg
Heinz Wiendl
Heinz Wiendl University of Münster

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering medical studies in the USA, there are various online programs that offer flexible, rewarding career paths in healthcare. For those interested in nursing, numerous nursing school that doesn't require teas provide an accessible route without the stress of additional entrance exams.

Looking to move into healthcare administration? Earning a healthcare administration associate degree online can open doors to management positions in hospitals, clinics, and insurance companies. For registered nurses wanting to advance, many opt for adn to fnp bridge programs, which enable a smooth transition from an Associate Degree in Nursing to becoming a Family Nurse Practitioner.

If nutrition and wellness are your passion, consider an online dietitian degree for a path in dietary science and public health. These online programs offer flexibility, allowing you to study at your own pace while gaining the skills needed for thriving healthcare careers.

Best Scientists Citing Patrick Vermersch

Trending Scientists

Recently Published Articles